Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838367 | 0.96 | MAPT (0.44) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL12233785 | 0.93 | POLB (0.37) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL15489690 | 0.93 | MAPT (0.39) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL10029314 | 0.93 | MAPT (0.44) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL838083 | 0.92 | MAPT (0.49) | MAPTPOLBSMN1; SMN2NPC1TSHR | |
| SCHEMBL10030725 | 0.92 | USP2 (0.41) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL4758832 | 0.92 | USP2 (0.41) | MAPTPOLBSMN1; SMN2NPC1USP2 | |
| SCHEMBL12091364 | 0.92 | MAPT (0.43) | MAPTPOLBSMN1; SMN2NPC1MEN1 | |
| SCHEMBL14369609 | 0.92 | SMN1; SMN2 (0.46) | MAPTPOLBSMN1; SMN2NPC1MAPK1 | |
| SCHEMBL401764 | 0.92 | RECQL (0.47) | MAPTPOLBSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170210922-A1 | 3D PRINTING SYSTEM COMPRISING SOLID BUILD INK COMPRISING COLORANT | XEROX CORPORATION | 2017-07-27 | — | — | US | disclosed |
| US-9676952-B2 | 3D printing system comprising solid build ink comprising colorant | XEROX CORPORATION (US) | 2017-06-13 | — | — | US | disclosed |
| US-20160244628-A1 | 3D PRINTING SYSTEM COMPRISING SOLID BUILD INK COMPRISING COLORANT | XEROX CORPORATION | 2016-08-25 | — | — | US | disclosed |
| US-20150145920-A1 | METHOD OF JETTING INK | XEROX CORPORATION (US) | 2015-05-28 | — | — | US | disclosed |
| US-9022546-B1 | Method of jetting ink | XEROX CORPORATION (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140171537-A1 | Orange Curable Ink | XEROX CORPORATION (US) | 2014-06-19 | — | — | US | disclosed |
| US-8714723-B2 | Robust curable solid inks and methods for using the same | XEROX CORPORATION (US) | 2014-05-06 | — | — | US | disclosed |
| US-8669298-B1 | Green curable ink | XEROX CORPORATION (US) | 2014-03-11 | — | — | US | disclosed |
| US-8652720-B2 | Super low melt toners | XEROX CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-8652574-B2 | Ink compositions | XEROX CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-20120282448-A1 | METHODS FOR FABRICATING THREE-DIMENSIONAL OBJECTS | XEROX CORPORATION (US) | 2012-11-08 | — | — | US | disclosed |
| US-8262210-B2 | Curable gel inks with reduced syneresis and halo formation | XEROX CORPORATION (US) | 2012-09-11 | — | — | US | disclosed |
| US-20120224230-A1 | WATERMARKING COMPRISING ULTRAVIOLET CURABLE SOLID INKS AND METHODS FOR PRODUCING THE SAME | XEROX CORPORATION (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120092426-A1 | CURABLE PHASE CHANGE INKS CONTAINING FUNCTIONALIZED ISOSORBIDES | XEROX CORPORATION (US) | 2012-04-19 | — | — | US | disclosed |
| US-8142557-B2 | Radiation curable ink containing gellant and radiation curable wax | XEROX CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-20120062669-A1 | CURABLE PHASE CHANGE INK CONTAINING ALKOXYSILANE MONOMER | XEROX CORPORATION (US) | 2012-03-15 | — | — | US | disclosed |
| US-8124193-B2 | Gloss control of UV curable formulations through micro-patterning | XEROX CORPORATION (US) | 2012-02-28 | — | — | US | disclosed |
| US-8105659-B2 | Method of controlling gloss with curing atmosphere using radiation curable ink or overcoat compositions | XEROX CORPORATION (US) | 2012-01-31 | — | — | US | disclosed |
| US-8043665-B2 | Method of controlling gloss in UV curable overcoat compostitions | XEROX CORPORATION (US) | 2011-10-25 | — | — | US | disclosed |
| US-20110177246-A1 | INK COMPOSITIONS | XEROX CORPORATION (US) | 2011-07-21 | — | — | US | disclosed |